Empire Financial Management Company, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1971875
NEW YORK, NY
Position in GILD
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$418,110
+$49,890 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empire Financial Management Company, LLC holds $13,403,297 across 5 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $418,110 | 3,000 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $368,220 | 3,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $288,600 | 2,600 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $288,262 | 2,600 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $291,330 | 2,600 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $240,162 | 2,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $217,984 | 2,600 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $219,552 | 3,200 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $234,400 | 3,200 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $259,232 | 3,200 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $254,796 | 3,400 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $262,038 | 3,400 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $381,662 | 4,600 | Shares | Sole | 2023-04-20 | |
| No filing history on record for this holder in this stock. | ||||||